MAXHEALTH NSI Week ended 07 Aug 2026

Weekly Investor Report

Max Healthcare Institute Limited · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 1,070 INR
-2.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 3.6% above the Trend Line and sits at 41.9% of its 52-week range. The latest completed week returned -2.6%, after a -3.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 47 out of 100
Latest Close 1,070 INR 7 Aug 2026
1W Return -2.6% latest completed week
4W Return -3.4% short-term follow-through
12W Return 2.1% quarterly tape
Trend Breadth 21.2% 11 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • Latest weekly return ranks in the weaker part of its sector group.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.6% Latest completed week; four-week move -3.4%. Indicator stack 29/63 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.42% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 27 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.6% above the Trend Line and sits at 41.9% of its 52-week range. The latest completed week returned -2.6%, after a -3.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3812-week average 0.22

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.38Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.4% over four weeks, 2.1% over 12 weeks, and -14.1% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-2.6%
4W-3.4%
12W2.1%
26W2.9%
52W-14.1%
Active trend streak5 weeks
Active weeks in one year11
Trend breadth21.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.88Latest activity-pressure read.
Pressure change-32.9%Four-week change in activity pressure.
Leadership0.15Latest relative-leadership reading.
RS change-96.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength14/100Blend of value, momentum, and quality. Underlying universe rank 87; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality89/100Profitability and accounting quality. Underlying universe rank 12; rank 1 is best.
Momentum28/100Medium-term price momentum. Underlying universe rank 73; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework24/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
72.2x
Price divided by trailing earnings.
Price / sales
12.4x
Market value relative to trailing revenue.
EV / EBITDA
45.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
78.6%
Gross profit retained from each unit of revenue.
Operating margin
21.5%
Operating profit retained from revenue.
Free-cash-flow margin
1.8%
Free cash flow generated from revenue.
Return on invested capital
9.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
19.0%
Latest one-year revenue growth.
EPS growth
33.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-69.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.2%
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 27 relevant articles.

3 positive · 20 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.8%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+8.1%Week of 19 Jun.
Worst week-5.7%Week of 29 May.
Latest week-2.6%Week of 7 Aug.

Shape of recent returns

Strong gains2
Modest gains12
Flat weeks0
Modest losses9
Sharp losses3
Recent vol3.7%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

 Indicator analysis59/100

Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 8/12.

Activity pressure 0.38; No reversal markers Next-Week ExpectancyPositive 56.42%

Next-week expectancy is positive with a 56.42% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors34/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74 SVQF24/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1198.5 of 1576 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 27 relevant articles.

Q1 Results 13th Aug Live: TMPV, Solar Ind, LG Electronics, Max Healthcare, GIC, Godrej Ind, Jubilant Foodworks, Amber Enterprises, Indraprastha Gas, Brigade, JSW Cement, Honasa Consumer to announce Q1 results, Tata Motors, HAL, Apollo Hospitals, Gr Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20261,070 INR-2.6%1,032 INR963.8 INR0.880.156.8MOn
31 Jul 20261,098 INR1.7%1,031 INR960.3 INR1.073.268.0MOn
24 Jul 20261,080 INR-0.9%1,029 INR956.7 INR1.163.936.7MOn
17 Jul 20261,090 INR-1.6%1,029 INR953.7 INR1.292.139.7MOn
10 Jul 20261,108 INR-3.9%1,029 INR950.5 INR1.304.209.7MOn
3 Jul 20261,153 INR2.9%1,028 INR947.3 INR1.068.051.5MOff
26 Jun 20261,121 INR2.6%1,026 INR943.8 INR0.645.830Off
19 Jun 20261,093 INR8.1%1,027 INR940.4 INR0.373.172.1MOff
12 Jun 20261,011 INR3.6%1,030 INR937.1 INR0.32-3.13760.5KOff
5 Jun 2026975.5 INR1.3%1,033 INR934.4 INR0.41-5.761.3MOff
29 May 2026963.4 INR-5.7%1,039 INR931.8 INR0.58-7.8424.4MOff
22 May 20261,021 INR-2.6%1,045 INR929.0 INR0.54-3.1819.9MOff
15 May 20261,048 INR3.7%1,050 INR925.9 INR0.27-0.519.3MOff
8 May 20261,011 INR2.0%1,055 INR922.7 INR0.09-6.278.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context